CJC-1295 and Ipamorelin Blend Explained

CJC-1295 and Ipamorelin are two of the most widely studied growth hormone secretagogues, and they are almost always mentioned together. There is a good reason for that: the two peptides act on different receptors and are frequently paired precisely because they complement each other. This guide explains what each one does, why the blend is so common in research, and how to buy CJC-1295 (No DAC) with Ipamorelin in Canada.

The two peptides, briefly

Both compounds influence the growth hormone axis, but through separate mechanisms:

• CJC-1295 is a growth hormone releasing hormone (GHRH) analogue. It engages the GHRH receptor, the pathway that signals for growth hormone release.
• Ipamorelin is a ghrelin receptor agonist, part of the growth hormone secretagogue receptor family. It works through a different receptor entirely.

Because they act on two distinct receptors, researchers study them together to look at how the two signals behave in combination rather than in isolation.

Why the blend is studied together

The logic behind pairing CJC-1295 with Ipamorelin is complementary signalling. One peptide engages the GHRH pathway while the other engages the ghrelin pathway, so together they let researchers examine two arms of the same axis at once. Ipamorelin is also valued for being selective, which makes it a clean partner in a combination study. That is why the two are so often supplied and discussed as a single blend.

CJC-1295: No DAC vs DAC

You will see CJC-1295 offered in two forms. The DAC version includes a Drug Affinity Complex, a modification that extends its half-life so it stays active far longer. The No DAC version, sometimes called modified GRF, has a much shorter half-life. When CJC-1295 is paired with Ipamorelin, the No DAC form is the one typically used, because its shorter action profile lines up more naturally with Ipamorelin. If you want the full breakdown, see our dedicated comparison of CJC-1295 No DAC versus DAC.

What to look for when buying the blend

A combination product only tells you as much as its documentation. When you source CJC-1295 with Ipamorelin, check that the supplier can confirm:

• Identity of both peptides in the blend, verified by mass spectrometry.
• Purity, confirmed by HPLC.
• A certificate of analysis for the specific lot you receive.

With a two-peptide product, that paperwork matters even more, because you want confidence in both components, not just one.

How the pairing is usually supplied

Because the two peptides are so often studied side by side, they are commonly offered as a single combined product rather than as two separate vials. That keeps the ratio of the two components consistent from lot to lot, which is one less variable to control for in your work. When you buy a blend, the key is that the supplier treats it as one documented product, with both peptides accounted for on the certificate of analysis rather than only the headline compound.

Buy CJC-1295 (No DAC) and Ipamorelin in Canada

At LYFE Science, CJC-1295 (No DAC) and Ipamorelin sit in our signalling research category. Every lot is verified by HPLC and mass spectrometry, with a COA available per lot, so you know exactly what is in each vial of the blend.

We are a Canadian supplier and ship Canada-wide by Canada Post: flat $25, free over $150, neutral packaging. Orders paid before noon Eastern go out the same day, and most of Canada receives delivery in one to three business days. Pay by Interac e-Transfer or crypto (BTC, ETH, SOL, USDC, USDT).

In short

• CJC-1295 is a GHRH analogue; Ipamorelin is a selective ghrelin receptor agonist.
• They are studied together because they engage complementary pathways.
• The No DAC form of CJC-1295 is the one typically paired with Ipamorelin.
• Buy from a supplier that documents both peptides with a per-lot COA.

Buy CJC-1295 and Ipamorelin in Canada